Bridgefront Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $435K | Buy |
+3,924
| New | +$435K | 0.12% | 308 |
|
|
2024
Q2 | – | Sell |
-9,424
| Closed | -$690K | – | 552 |
|
|
2024
Q1 | $690K | Buy |
+9,424
| New | +$690K | 0.52% | 32 |
|
|
2023
Q3 | – | Sell |
-5,890
| Closed | -$454K | – | 471 |
|
|
2023
Q2 | $454K | Buy |
+5,890
| New | +$454K | 0.25% | 136 |
|
|
2022
Q3 | – | Sell |
-3,564
| Closed | -$220K | – | 372 |
|
|
2022
Q2 | $220K | Buy |
+3,564
| New | +$220K | 0.24% | 207 |
|
|
2021
Q3 | – | Sell |
-4,039
| Closed | -$278K | – | 472 |
|
|
2021
Q2 | $278K | Buy |
+4,039
| New | +$278K | 0.1% | 376 |
|